ES2064856T3 - Composiciones farmaceuticas que contienen compuestos triciclicos. - Google Patents

Composiciones farmaceuticas que contienen compuestos triciclicos.

Info

Publication number
ES2064856T3
ES2064856T3 ES91118592T ES91118592T ES2064856T3 ES 2064856 T3 ES2064856 T3 ES 2064856T3 ES 91118592 T ES91118592 T ES 91118592T ES 91118592 T ES91118592 T ES 91118592T ES 2064856 T3 ES2064856 T3 ES 2064856T3
Authority
ES
Spain
Prior art keywords
pharmaceutical compositions
compositions containing
tricyclic compounds
containing tricyclic
chem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91118592T
Other languages
English (en)
Inventor
Sotoo Asakura
Michiyo Fukae
Shigeo Nakanishi
Yasuto Koyama
Youhei Kiyota
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2064856T3 publication Critical patent/ES2064856T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Transplantation (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

UN COMPUESTO FARMACEUTICO, EN EMULSION O EN SOLUCION, EN UN DISOLVENTE ORGANICO CONTIENE UNA PREPARACION REPRESENTADA POR LA SIGUIENTE FORMULA, CON ACTIVIDAD INMUNOREPRESORA, QUE ES REVELADA AQUI:
ES91118592T 1990-11-02 1991-10-31 Composiciones farmaceuticas que contienen compuestos triciclicos. Expired - Lifetime ES2064856T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP29813590 1990-11-02
JP29813690 1990-11-02

Publications (1)

Publication Number Publication Date
ES2064856T3 true ES2064856T3 (es) 1995-02-01

Family

ID=26561392

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91118592T Expired - Lifetime ES2064856T3 (es) 1990-11-02 1991-10-31 Composiciones farmaceuticas que contienen compuestos triciclicos.

Country Status (17)

Country Link
US (1) US5955469A (es)
EP (1) EP0483842B1 (es)
JP (1) JPH059117A (es)
KR (1) KR100206722B1 (es)
CN (1) CN1069194C (es)
AT (1) ATE115400T1 (es)
AU (1) AU655603B2 (es)
CA (1) CA2054629C (es)
DE (1) DE69105915T2 (es)
DK (1) DK0483842T3 (es)
ES (1) ES2064856T3 (es)
HU (1) HU217540B (es)
IE (1) IE66592B1 (es)
PH (1) PH31204A (es)
PT (1) PT99398B (es)
RU (1) RU2084222C1 (es)
UA (1) UA43820C2 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0689426T3 (da) * 1993-03-22 2000-10-30 Cognis Australia Pty Ltd Terapeutisk middel til behandling af melanomer
EP0689427B1 (en) * 1993-03-22 2002-06-12 Cognis Australia Pty Ltd Water dispersible therapeutic carotenoid compounds
DE4447972B4 (de) * 1993-05-27 2007-12-27 Novartis Ag Galenische Formulierungen
CH686761A5 (de) 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
AT408520B (de) * 1993-05-27 2001-12-27 Novartis Erfind Verwalt Gmbh Galenische formulierungen
GB2278780B (en) * 1993-05-27 1998-10-14 Sandoz Ltd Macrolide formulations
GB2315216B (en) * 1993-10-05 1998-10-14 Ciba Geigy Ag Microemulsion preconcentrates comprising FK506 or 33-epi-chloro-33-desoxy-ascomycin
AU714254B2 (en) * 1994-10-26 1999-12-23 Novartis Ag Pharmaceutical compositions
ATE254450T1 (de) 1995-09-19 2003-12-15 Fujisawa Pharmaceutical Co Aerosolzusammensetzungen
US6864232B1 (en) 1998-12-24 2005-03-08 Sucampo Ag Agent for treating visual cell function disorder
GB0108498D0 (en) * 2001-04-04 2001-05-23 Novartis Ag Organic Compounds
PE20030828A1 (es) * 2002-03-04 2003-11-04 Novartis Ag Composicion oftalmica que comprende ascomicina
JP2005230125A (ja) 2004-02-17 2005-09-02 Aruze Corp ゲーム装置及びゲームプログラム
KR100866728B1 (ko) * 2004-11-12 2008-11-03 주식회사종근당 타크로리무스를 함유하는 주사제
CN101869547B (zh) 2009-04-24 2012-02-22 张娜 一种他克莫司注射制剂
KR101230573B1 (ko) * 2010-04-21 2013-02-06 닥터후 주식회사 천년초 추출물 또는 백년초 추출물을 함유하는 천연 유화제 및 이를 포함하는 화장품 조성물, 식품 조성물 및 의약 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894366A (en) * 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
PH26083A (en) * 1987-11-09 1992-02-06 Sandoz Ltd 11, 28-dioxa-4-azatricyclo [22.3.1.04.9) octacos-18-ene derivatives and pharmaceutical compositions containing them and method of use thereof
EP0346427B1 (en) * 1987-12-09 1995-03-29 FISONS plc Macrocyclic compounds
EP0356399A3 (en) * 1988-08-26 1991-03-20 Sandoz Ag Substituted 4-azatricyclo (22.3.1.04.9) octacos-18-ene derivatives, their preparation and pharmaceutical compositions containing them
GB8925797D0 (en) * 1989-11-15 1990-01-04 Fisons Plc Compositions
US5260301A (en) * 1990-03-01 1993-11-09 Fujisawa Pharmaceutical Co., Ltd. Pharmaceutical solution containing FK-506

Also Published As

Publication number Publication date
JPH059117A (ja) 1993-01-19
DK0483842T3 (da) 1995-02-20
CA2054629A1 (en) 1992-05-03
KR920009400A (ko) 1992-06-25
HU217540B (hu) 2000-02-28
DE69105915D1 (de) 1995-01-26
PH31204A (en) 1998-05-05
CN1061153A (zh) 1992-05-20
HU343891D0 (en) 1992-01-28
AU8692291A (en) 1992-05-07
PT99398B (pt) 1999-04-30
CN1069194C (zh) 2001-08-08
ATE115400T1 (de) 1994-12-15
RU2084222C1 (ru) 1997-07-20
HUT60924A (en) 1992-11-30
EP0483842A1 (en) 1992-05-06
IE66592B1 (en) 1996-01-24
KR100206722B1 (ko) 1999-07-01
EP0483842B1 (en) 1994-12-14
PT99398A (pt) 1992-09-30
AU655603B2 (en) 1995-01-05
IE913813A1 (en) 1992-05-22
UA43820C2 (uk) 2002-01-15
US5955469A (en) 1999-09-21
DE69105915T2 (de) 1995-05-04
CA2054629C (en) 2002-04-16

Similar Documents

Publication Publication Date Title
ES2064856T3 (es) Composiciones farmaceuticas que contienen compuestos triciclicos.
ES2069137T3 (es) Derivados de imidazopiridina y su uso.
NO904377L (no) Tricykliske karbapenemforbindelser.
DK0444659T3 (da) Farmaceutisk opløsning indeholdende derivater af FK 506
ATE157089T1 (de) Derivate von alkanolaminen als kardiovaskuläre mittel
BR9201854A (pt) Composto derivado de pridazinas,processo para sua preparacao,e,composicao farmaceutica
ATE204576T1 (de) Methotrexat-derivate
KR960007592A (ko) 신규한 피롤로카바졸
MX9300433A (es) Compuestos de piridincarboximidamina y composiciones farmaceuticas que los contienen.
ATE144498T1 (de) Herstellung von substituierten piperidinen
FI932992A0 (fi) Fungisida fenylbenzamider och foerfaranden foer framstaellning daerav
MX9203360A (es) Derivados de hexahidroazepinas y composiciones farmaceuticas que los contienen.
DE69413112T2 (de) 5-HT3 Pyrrolopyrazinderivate
DK0576330T3 (da) Fremgangsmåde til fremstilling af delta-9(11)-steroidforbindelser
KR920002613A (ko) 이환성 함유 황화합물
DE69217148D1 (de) Isoxazole derivate als lichtschutzmittel
ATE117682T1 (de) Substituierte benzothiazolinone, ihre herstellung und sie enthaltende pharmazeutische zusammenstellungen.
TH13552EX (th) อนุพันธุ์ต่าง ๆ ของเบนโซฟิโนน
ATE125790T1 (de) N-fumaramidsäurederivate und diese enthaltende fungizide.
KR910021373A (ko) 1-페녹시카보닐-2-피롤리디논 유도체 및 향정신성 약제
TH15376A (th) อนุพันธ์กรดไฮดรอกเซมิค
TH14336EX (th) อนุพันธ์ต่าง ๆ ของพิเพอริดีน

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 483842

Country of ref document: ES